Comorbidities and use of proarrhythmic drugs in patients with torsade de pointes arrhythmia

Back

ESC Professional Premium Access

Comorbidities and use of proarrhythmic drugs in patients with torsade de pointes arrhythmia

Session: Sudden cardiac death: insight

Topic: Risk Factors and Risk Assessment

Speaker: Doctor K. Nowinski (Stockholm, SE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Karolina Nowinski

Karolinska Institute, Stockholm (Sweden)

0 follower

5 more presentations in this session

Role of ventricular tachycardia cycle length in the outcomes after catheter ablation or antiarrhythmic drugs in the SURVIVE-VT trial

Speaker: Doctor P. Avila Alonso (Madrid, ES)

High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: a multicenter cohort study and review of the literature

Speaker: Mr M. Tukker (Rotterdam, NL)

Significance of J wave with inverted ST-T polarity induced by ill-timed atrial premature beats and its association with Torsade de Pointes in patients with acute acquired long QT syndrome

Speaker: Doctor H. Ichiryu (Gifu, JP)

Prevalence and characteristics of the catecholamine induced QT prolongation syndrome

Speaker: Professor V. Probst (Nantes, FR)

Identification of genetic variants by using a whole exome sequencing approach in Taiwanese patients with Brugada Syndrome

Speaker: Doctor J. Juang (Taipei, TW)

Access the full session

Sudden cardiac death: insight

Speakers: Doctor K. Nowinski, Doctor P. Avila Alonso, Mr M. Tukker, Doctor H. Ichiryu, Professor V. Probst...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources